Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion [Corrigendum]
Tagami M, Sai R, Fukuda M, Azumi A. Clin Ophthalmol. 2017;11:403–408.
Page 405, Comparison of injection intervals section, line 6, “We also compared the intervals between the last and the second-to the-last intravitreal injection of ranibizumab and first and the second intravitreal injection of aflibercept” should have read “We also compared the interval between the last injection of ranibizumab and the first injection of aflibercept with the interval between the first and the second injection of aflibercept”.
Read the original article
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]
Other article by this author:
Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion
Tagami M, Sai R, Fukuda M, Azumi A
Published Date: 22 February 2017